| Literature DB >> 31927477 |
Marta A Fik-Jaskółka1, Anna F Mkrtchyan2, Ashot S Saghyan2, Rosanna Palumbo3, Agnieszka Belter4, Liana A Hayriyan2, Hayarpi Simonyan5, Valentina Roviello6, Giovanni N Roviello7.
Abstract
Herein, we present a spectroscopic (CD and UV) and SEM study of a phenylalanine derivative carrying a terminal alkyne moiety and indicated by us CF3IIIPhe, with particular attention to its interaction with Cu(II) cation and some biological macromolecules, as well as a preliminary evaluation of its effect on cancerous cells. CD spectroscopy evidenced the ability of CF3IIIPhe to interact with tel26 and c-myc, two quadruplex DNA (G4 DNA) models explored in this study. Other CD and UV studies revealed the ability of the unnatural amino acid to form aggregates in aqueous solution, to bind Cu(II) cation, and to interact with bovine serum albumin (BSA). Cellular studies demonstrated CF3IIIPhe antiproliferative activity on PC3 cells. Its ability to bind telomeric DNA was verified with tel26 by CD investigation and SEM analysis, that revealed a noteworthy change in DNA morphology (mainly based on nanosphere structures) by CF3IIIPhe, confirming its G4-DNA binding ability already evidenced by spectroscopy.Entities:
Keywords: Anticancer drugs; BSA; DNA quadruplex, telomeric DNA; Ni(II)-complex intermediates; Unnatural amino acids; c-myc; copper-binding
Year: 2019 PMID: 31927477 DOI: 10.1016/j.saa.2019.117884
Source DB: PubMed Journal: Spectrochim Acta A Mol Biomol Spectrosc ISSN: 1386-1425 Impact factor: 4.098